PAMU
TLIS

Pictet Asset Management (UK)’s Talis Biomedical Corporation Common Stock TLIS Stock Holding History

Pictet Asset Management (UK)’s Portfolio TLIS Stock Details TLIS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$373K Sell
2,256
-11,434
-84% -$1.94M ﹤0.01% 1330
2021
Q1 		$2.64M Buy
+13,690
New +$3.41M ﹤0.01% 949

Other funds holding TLIS

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
NIP
Nicholas Investment Partners Rancho Santa Fe, California $1.39B AUM 97.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Pictet Asset Management (UK)'s TLIS Position: Q2 2021 in Review

Pictet Asset Management (UK) reduced its Talis Biomedical Corporation Common Stock (TLIS) stake by 84% in Q2 2021, selling an estimated $1.94M and leaving 2,256 shares worth $373K. The position accounts for ﹤0.01% of the portfolio, ranked #1330.

Pictet Asset Management (UK) first reported a position in TLIS in Q1 2021 and has held it in 2 quarters since. The position peaked at $2.64M in Q1 2021. 43 funds tracked by Wall St. Rank hold TLIS as of Q2 2021.

  • Pictet Asset Management (UK) held 2,256 shares of Talis Biomedical Corporation Common Stock worth $373K as of Q2 2021.
  • Pictet Asset Management (UK) sold 11,434 Talis Biomedical Corporation Common Stock shares in Q2 2021, an estimated $1.94M.
  • Talis Biomedical Corporation Common Stock made up ﹤0.01% of Pictet Asset Management (UK)'s portfolio in Q2 2021, its #1330 holding.
  • Pictet Asset Management (UK) first reported a position in Talis Biomedical Corporation Common Stock in Q1 2021 and has held it in 2 quarters since.
  • Pictet Asset Management (UK)'s Talis Biomedical Corporation Common Stock position peaked at $2.64M in Q1 2021.
  • 43 funds tracked by Wall St. Rank held Talis Biomedical Corporation Common Stock as of Q2 2021.

Based on Pictet Asset Management (UK)'s 13F filing for Q2 2021, filed 16 Aug 2021.